Fig. 1 · Structure

Documents & Downloads

Tepilukimig

Anti-TSLP-IL7Rα/CRLF2 Antibody

Tepilukimig is a humanized IgG1κ monoclonal antibody that targets TSLP-IL7Rα and TSLP-CRLF2 interactions. By inhibiting the binding of TSLP to its receptors on the cell surface, Tepilukimig effectively disrupts the inflammatory signaling pathway mediated by TSLP. This reagent is suitable for research applications related to allergic and inflammatory diseases, including atopic dermatitis and asthma.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 2985643-31-8
Applications Anti-TSLP-IL7Rα/CRLF2 Antibody

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...